Form 4 for GDRX GoodRx Holdings, Inc.
Accepted 2021-10-21 00:00:00 ET · period of report 2021-10-19 · accession 0000899243-21-040972 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-21 | 2021-10-19+ | GDRX | NAGJI BANSI | Pres, Healthcare | M - OptEx | $6.84 | +16.4K | 16.3K | New | +$112.2K |
| DM | 2021-10-21 | 2021-10-19+ | GDRX | NAGJI BANSI | Pres, Healthcare | S - Sale+OE | $45.00 | -16.4K | 0 | -100% | -$738.0K |
| DM | 2021-10-21 | 2021-10-19 | GDRX | NAGJI BANSI | Pres, Healthcare | M - OptEx | $0.00 | -16.4K | 305.9K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-10-19 | M | A | 100 | $6.84 | 100 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-10-20 | S | D | 16,300 | $45.00 | 0 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-10-20 | M | A | 16,300 | $6.84 | 16,300 | D | — | — | |
| 4 | Common | Class A Common Stock | 2021-10-19 | S | D | 100 | $45.02 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-10-19 | M | D | 16,300 | $0.00 | 289,584 | D | $6.84 · — to 2030-06-15 | 16,300 Class A Common Stock | (F2) The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-10-19 | M | D | 100 | $0.00 | 305,884 | D | $6.84 · — to 2030-06-15 | 100 Class A Common Stock | (F2) The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. |